An underground market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.
Experimental Treatment Acquiring Traction Via Social Media
The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Sellers market the substance there before directing buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.
Some experts stated the demand for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate medicines, marketing, and customer regulations, risking fines, prosecution or imprisonment.
Platform Response and Material Elimination
Based on the social media company, the service has removed problematic material and prohibited related hashtags and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in enhancing compliance measures.
Online Trading Activities
Research also found communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, populated with photos of weight loss, positive testimonials and detailed instructions for mixing or injecting at residence.
Within minutes of entering one group, a vendor shared contact information, where most transactions take place. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.
Product Information and Costs
Within these groups, posts show black plastic parcels with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A representative for Telegram said it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.
Her team has already seen patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to possibly significant health risks”.
